Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors

• Main Authors: Francesca Barei (Author), Paolo Calzari (Author), Luca Valtellini (Author), Alessandra Chiei Gallo (Author), Gabriele Perego (Author), Simona Tavecchio (Author), Martina Zussino (Author), Angelo V. Marzano (Author), Silvia Ferrucci (Author)
• Format: Book
• Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Atopic dermatitis (AD) profoundly impacts patients' lives, necessitating long-term systemic treatments.Methods This retrospective study involved 709 severe AD patients receiving dupilumab. Drug survival (DS) was analyzed using Kaplan-Meier curves, evaluating reasons for discontinuati...